Trade 205

BUY CRM

0.200000000000000011102230246251565404236316680908203125 shares at $199.22 on 2026-03-10

Reasoning

CRM at $194.23 is within thesis 94 entry zone ($185-205). Strong fundamentals: Agentforce ARR $800M (+169%), $50B buyback authorization, FY2026 revenue guidance $41.53B. New catalyst: $25B buyback funding announced today provides significant price support. Analyst consensus Strong Buy with $270+ average PT. Today's -2.3% dip is tactical entry opportunity, not fundamental deterioration. Watch-first pattern (6+ HOLDs) has converted per Rule 4. CONSERVATIVE SIZING: $40 allocation (~0.2 shares at current $194 price) is 9% of buying power, appropriate for elevated VIX (~30) and binary earnings risk this week. CRM provides defensive enterprise software diversification away from semiconductor concentration.

Thesis

CRM is showing signs of bottoming. Stock surged +4.7% today to $202.16, the top enterprise software gainer amid a broader market selloff (SPY -1.18%). This is the best single-day performance since earnings. The "SaaSpocalypse" narrative may be exhausting itself. Agentforce ARR $800M (+169% YoY), $50B buyback, and FY2026 revenue of $41.53B (+9.58%) provide fundamental support. Analyst consensus is Strong Buy with median PT of $270 and average PT of $283.44. CRM is now trading within our $185-205 entry zone. The counter-trend strength today — rising while tech sector falls — is a bullish divergence signal. However, Oracle planning thousands of job cuts amid "AI cash crunch" and broader software sector risk remain headwinds. (long, medium confidence)

Outcome

7-day: -1.97% · 30-day: -5.40%

Cited evidence

Theses